loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 22472 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Mannkind

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 INSULIN RECOMBINANT HUMAN (3)

    filter

    01 MANNKIND (3)

    filter

    01 POWDER;INHALATION (3)

    filter

    01 12 UNITS/INH (1)

    02 4 UNITS/INH (1)

    03 8 UNITS/INH (1)

    filter

    01 USA (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Insulin Recombinant Human

      PDF Supplier PDF
      URL Supplier Web Content
      POWDER;INHALATION
      4 UNITS/INH
      AFREZZA
      USA
      22472
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Insulin Recombinant Human

        PDF Supplier PDF
        URL Supplier Web Content
        POWDER;INHALATION
        8 UNITS/INH
        AFREZZA
        USA
        22472
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag U.S.A
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Insulin Recombinant Human

          PDF Supplier PDF
          URL Supplier Web Content
          POWDER;INHALATION
          12 UNITS/INH
          AFREZZA
          USA
          22472
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Looking for CTD TGA MCC DOSSIER APPLICATION 22472

          Looking for CTD TGA MCC DOSSIER APPLICATION 22472 3

          19

          Mannkind, based in U.S.A, is a pharmaceutical company.

          One of their notable products is INSULIN RECOMBINANT HUMAN, with a corresponding application number 22472 and regulatory information .

          proudly manufactured in the

          Mannkind's AFREZZA POWDER;INHALATION, medication with 4 UNITS/INH of INSULIN RECOMBINANT HUMAN.

          18

          Mannkind, based in U.S.A, is a pharmaceutical company.

          One of their notable products is INSULIN RECOMBINANT HUMAN, with a corresponding application number 22472 and regulatory information .

          proudly manufactured in the

          Mannkind's AFREZZA POWDER;INHALATION, medication with 8 UNITS/INH of INSULIN RECOMBINANT HUMAN.

          17

          Mannkind, based in U.S.A, is a pharmaceutical company.

          One of their notable products is INSULIN RECOMBINANT HUMAN, with a corresponding application number 22472 and regulatory information .

          proudly manufactured in the

          Mannkind's AFREZZA POWDER;INHALATION, medication with 12 UNITS/INH of INSULIN RECOMBINANT HUMAN.

          Post Enquiry
          POST ENQUIRY